Table 3.
Leukocyte counts and inflammatory cytokines at baseline and follow up
| |
Intervention group |
Control group |
P -value | ||
|---|---|---|---|---|---|
| Baseline | Follow up | Baseline | Follow up | ||
| Leukocyte counts |
|
|
|
|
|
| Total leukocyte count (103 cells/μl) |
5.145 (1.417) |
5.156 (1.337) |
5.184 (1.237) |
5.594 (1.370) |
0.04 |
| Neutrophil count (103 cells/μl) |
3.014 (1.119) |
2.958 (1.135) |
3.131 (0.912) |
3.377 (1.061) |
0.05 |
| Monoctye count (103 cells/μl) |
0.400 (0.370, 0.430) |
0.400 0.360, 0.440 |
0.400 (0.350, 0.450) |
0.400 (0.350, 0.450) |
0.63 |
| Lymphocyte count (103 cells/μl) |
1.507 (0.414) |
1.523 (0.389) |
1.446 (0.497) |
1.612 (0.449) |
0.04 |
| CD3+CD4+T cells (103cells/μl) |
0.748 (0.596, 0.900) |
0.682 (0.605, 0.759) |
0.659 (0.532, 0.786) |
0.763 (0.648, 0.878) |
0.02 |
| CD3+CD8+ T cells (103cells/μl) |
0.474 (0.365, 0.583) |
0.402 (0.334, 0.470) |
0.360 (0.214, 0.506) |
0.409 (0.322, 0.496) |
0.05 |
| CD4+:CD8+ ratio |
1.62 (1.36, 1.88) |
1.69 (1.40, 1.98) |
1.93 (1.51, 2.35) |
1.91 (1.49, 2.33) |
0.87 |
| NK cells (103 cells/μl) |
0.200 (0.175, 0.225) |
0.206 (0.177, 0.235) |
0.176 (0.147, 0.205) |
0.174 (0.144, 0.292) |
0.46 |
| Inflammatory cytokines |
|
|
|
|
|
| IL-6 (ρg/mL) |
1.599 (1.259, 1.906) |
1.692 (1.377, 2.007) |
1.755 (1.456, 2.054) |
1.942 (1.602, 2.282) |
0.93 |
| TNF-α(ρg/mL) | 0.889 (0.779, 0.999) | 0.916 (0.767, 1.065) | 1.058 (0.895, 1.221) | 0.992 (0.870, 1.114) | 0.61 |
Data are presented as means (SD) or medians (semi-interquartile range). P-value shown for between-group comparisons. P-values in boldface significant at alpha 0.05. NK, natural killer.